PNOC041: Metformin in Patients with Recurrent or Progressive PFA Ependymoma

PNOC041: Metformin in Patients with Recurrent or Progressive PFA Ependymoma

Es posible que algunos contenidos no estén disponibles en español.

Study Details

Full Title

PNOC041: A Target Validation and Efficacy Study of Metformin in Patients with Recurrent or Progressive Posterior Fossa Group A (PFA) Ependymoma

Principal Investigator

Daniel
Landi

Protocol Number

PRO00119661

NCT ID

NCT07226453

Phase

I/II

Enrollment Status

Open to Enrollment
ClinicalTrials.gov